Recent News for SER - Serina Therapeutics, Inc.

Date	Title
Nov 12	AgeX Therapeutics GAAP EPS of $0.13, revenue of $0.01M
Nov 12	Serina Therapeutics Reports Third Quarter 2024 Financial Results and Provides Business Highlights
Sep 4	Serina Therapeutics to Present at the H.C. Wainwright 26th Annual Global Investment Conference
Jul 29	Serina Therapeutics to Present Novel Data on POZ-Lipid Technology Potentially Enhancing Safety and Efficacy of mRNA LNP Formulations at the 4th mRNA-Based Therapeutics Summit
Jul 18	Serina Therapeutics Appoints Srini Tenjarla, Ph.D. as Senior Vice President of CMC and Formulation